A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
Clinical trial NCT07233239 · RECRUITING
Trial details
- NCT number
- NCT07233239
- Sponsor
- Jazz Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-26
- Primary completion
- 2027-11-29
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.